Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, Koebnick C
P.XiaY.LiY
This discrepancy may be the result of the different mechanisms by which the two toxins act on mitochondria (Bove et al., 2010)
These data suggest that NRF2 activation following GSH depletion causes repression of LXR activity, leading to lower expression of lipogenic enzymes and lower levels of serum triglycerides
One line summary of the article The article explores the potential of GLP-1 receptor agonists as a novel treatment option for alcohol use disorder (AUD) by highlighting both preclinical and clinical research findings
ALC is a highly bioavailable form of carnitine that can cross the blood-brain barrier, where it helps to manage oxidative damage, supports mitochondrial function and helps to maintain normal neurotransmitter activity.* Clinical studies suggest that ALC helps to maintain optimal neurological health.*